Pulsenmore News
30 articles
growth-positive
Middle Eastern Penny Stocks To Watch In October 2025
Taaleem Holdings PJSC, a company operating in the United Arab Emirates, focuses on providing and investing in education services. With a market capitalization of AED4.25 billion, the company reported an increase in sales to AED1.14 billion for fiscal 2025, up from AED946.88 million the previous year. Despite a slight decrease in net profit margins from 15.3% to 14%, Taaleem Holdings maintains high-quality earnings and has not diluted shareholders over the past year. The company benefits from seasoned management and board teams, contributing to its stability. While short-term assets exceed short-term liabilities, long-term liabilities are not fully covered by current assets.
growth-negative
Middle Eastern Market Gems: Formet Metal ve Cam Sanayi Among 3 Promising Penny Stocks
The article discusses the fluctuations in Middle Eastern markets, focusing on penny stocks with potential for growth. Formet Metal ve Cam Sanayi A.S., a Turkish company manufacturing steel doors, is highlighted for its financial health despite ongoing profitability challenges. The company has improved its debt to equity ratio and maintains a stable cash runway due to positive free cash flow. However, it faces challenges with increased annual losses and a net loss in recent earnings. The article provides insights into the companys financial performance and potential for long-term success.
growth-positive
Middle Eastern Penny Stocks With Over US$40M Market Cap To Watch
Formet Metal ve Cam Sanayi A.S., a Turkish company specializing in steel doors, has shown financial improvement with a market cap of TRY2.02 billion and revenue from its Building Products segment at TRY631.26 million. The company has reduced its debt to equity ratio significantly over the past five years, now at a satisfactory 23.4%. Despite a large one-off gain of TRY20.1 million impacting earnings, the company maintains strong liquidity with short-term assets exceeding liabilities. However, the management team lacks seasoned experience, and the stock remains highly volatile compared to most Turkish stocks, despite stable weekly volatility recently.
growth-positive
Middle Eastern Penny Stocks To Watch: 3 Picks Under US$100M Market Cap
Formet Metal ve Cam Sanayi A.S., a Turkish company specializing in steel doors, has demonstrated financial improvement by becoming profitable in Q1 2025 with a net income of TRY98.41 million, reversing a previous loss. The company shows strong liquidity, with short-term assets surpassing liabilities, and a reduced debt to equity ratio of 27.4% over five years. Despite these positive financial indicators, the company faces challenges such as volatility in share price and a board lacking experience, which may concern potential investors. The article highlights the companys financial health and potential for growth amidst a volatile market environment.
growth-positive
Middle Eastern Penny Stocks To Watch In June 2025
Formet Metal ve Cam Sanayi A.S., a Turkish company specializing in steel doors, has demonstrated a positive financial turnaround by becoming profitable in the past year. The company reported a net income of TRY98.41 million for Q1 2025, marking a significant improvement from previous losses. With a market cap of TRY2 billion, Formet Metal has reduced its debt significantly over the past five years, achieving a satisfactory net debt to equity ratio of 23.4%. Despite recent earnings being influenced by one-off gains, the companys short-term assets exceed both short-term and long-term liabilities, providing financial stability. However, the boards lack of seasoned experience, with an average tenure of just one year, is noted as a potential concern.
growth-negative
3 Middle Eastern Penny Stocks With Over US$20M Market Cap
Formet Metal ve Cam Sanayi A.S., a company in the steel door industry, has faced financial challenges with a net loss of TRY152.44 million in 2024, down from TRY751.38 million in revenue the previous year. Despite these challenges, the company has improved its debt management, reducing its debt to equity ratio from 87.9% to 35.2%. The company recently raised TRY538.13 million through a follow-on equity offering, which may provide some financial relief. However, the high share price volatility remains a concern for investors seeking stability in penny stocks.
PIPE/PO
growth-positive
3 Penny Stocks With Market Caps Under US$70M To Consider
Sivers Semiconductors AB, a company in the semiconductor sector, is experiencing potential growth opportunities despite current financial challenges. The company has secured significant contracts under the U.S. CHIPS Act for RF technology development with industry leaders such as BAE Systems and Raytheon. Additionally, Sivers is involved in a major telecom chip development program valued at $5.4 million through 2026. These strategic partnerships and contracts are expected to bolster Sivers financial position, even though it currently faces challenges like a limited cash runway and negative equity returns.
Partners
growth-positive
Pulsenmore Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care
Pulsenmore, a leader in home-based ultrasound technology, has renewed and expanded its strategic partnership with Clalit Health Services, Israels largest HMO. Over the next five years, Pulsenmore will supply 25,000 advanced home ultrasound devices to Clalit, enhancing prenatal care accessibility. The devices will now support both asynchronous and synchronous scans, allowing real-time video consultations. Clalit will also evaluate Pulsenmores Biophysical Profile feature for high-risk pregnancies. Pulsenmores technology enables pregnant women to perform self-guided scans at home, sending data to medical teams for review. The company has seen significant growth, with a 79% revenue increase in the first half of the year and new distribution agreements in key markets.
PartnersCustomers
growth-positive
Pulsenmore Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care
Pulsenmore, a leader in home-based ultrasound technology, has renewed and expanded its strategic partnership with Clalit Health Services, Israels largest HMO. Over the next five years, Pulsenmore will supply 25,000 units of its advanced home ultrasound devices to Clalit, enhancing prenatal care accessibility. The devices will allow pregnant women to conduct ultrasound scans at home, both asynchronously and synchronously, with real-time video consultations. This partnership reinforces Clalits trust in Pulsenmores solutions and marks a significant milestone in remote healthcare. Pulsenmore has seen a 79% revenue growth in the first half of the year and continues to expand globally with new distribution agreements.
Partners
growth-positive
Pulsenmore Appoints Len Farris as Chief Commercial Officer to Lead Global Expansion of Breakthrough Home Ultrasound Technology
Pulsenmore Ltd., a pioneer in home ultrasound imaging technology, has appointed Len Farris as Chief Commercial Officer. Farris will lead Pulsenmores global commercial growth, overseeing sales, business development, and partnerships. The companys innovative tele-ultrasound solution allows pregnant women to perform self-scans at home using a smartphone-connected device. The platform has already gained commercial traction with over 120,000 home ultrasound scans performed by expectant mothers, and remotely interpreted by sonographers and obstetricians, through significant collaborations with HMOs, hospitals and partners across Europe, Brazil and Israel.
Management ChangesExpand
growth-positive
DIY Ultrasound Startup Assesses Expanded Capabilities In US Study
Pulsenmore, an Israeli company that manufactures a DIY ultrasound device for pregnant women, has initiated a new clinical study in partnership with Michigan Medicine, the University of Michigan’s academic medical center. The study aims to assess the devices ability to conduct a remote biophysical profile (BPP) test, which is typically performed in a clinical setting to measure the health of a fetus. The Pulsenmore device is already available in Israel and the company plans to expand its market to Australia, Brazil, Europe, Switzerland, and the UK.
PartnersExpand
growth-positive
Pulsenmore is expanding the application of its home ultrasound solution for pregnant women: a clinical trial with Michigan Medicine will focus on the remote assessment of the fetal biophysical profile
Pulsenmore, a leader in self-scan ultrasound technology for home use and remote clinical diagnosis, has announced a new clinical study collaboration with Michigan Medicine. The study will examine the ability to conduct a remote biophysical profile (BPP) test using the Pulsenmore home ultrasound with the guidance of a remote clinician. This could potentially reduce the clinical burden. The Pulsenmore prenatal home ultrasound allows pregnant women to perform ultrasound imaging scans from home, which are then transmitted to the hospital for evaluation. The company recently announced a commitment agreement with Sheba BEYOND virtual hospital.
PartnersExpand
growth-positive
Pulsenmore Receives Brazilian ANVISA Approval for Its Prenatal Home Ultrasound Solution
Pulsenmore, a global leader in self-scan ultrasound technology for home use, has received approval from the Brazilian Health Regulatory Agency (ANVISA) for its prenatal care solution. This approval marks a significant milestone in the companys international expansion, particularly in Latin America. Pulsenmores technology allows pregnant women to conduct ultrasound imaging scans from home, with the scans transmitted to remote hospitals or clinics for evaluation. The approval enables Pulsenmore to provide Brazilian health organizations and consumers with access to this solution, reducing the need for in-clinic visits.
CustomersExpand
growth-positive
Pulsenmore מתחילה בייצור המוני של אולטראסאונד ביתי - Techtime - חדשות אלקטרוניקה והייטק
Pulsenmore, an Israeli company, has begun mass production of a home ultrasound device for pregnant women that operates on iOS. The device allows women to perform ultrasound tests at home and send the images to their doctor via their smartphone. The company has developed two systems: the Pulsenmore ES for use by pregnant women, and the Pulsenmore FC which allows women undergoing IVF to perform a self-examination of follicle size. The company expects to deliver about 25,000 devices to customers in 2023 and about 70,000 in 2024. Pulsenmore has received large orders from GE Healthcare and Clalit Health Services. The company is also developing its own manufacturing process for ultrasonic transducers.
CustomersExpand
growth-positive
Pulsenmore מתרחבת: הכפילה את כמות העובדים והרחיבה יכולות פיתוח - וואלה! כסף
Pulsenmore, the manufacturer of the worlds first home ultrasound for pregnancy, has doubled its number of employees in the past year and launched new offices. The companys technology allows pregnant women to perform ultrasound scans at home by connecting their smartphones to a compact and innovative ultrasound device. The scans are automatically sent for evaluation and interpretation by experts, and the results are documented in the medical record and sent to the pregnant woman via SMS. Pulsenmore has recently announced a partnership with GE Healthcare, which will invest up to $50 million in the company and distribute its products in selected markets in Europe, the United States, and Japan. GE has already invested $21 million. Pulsenmore has also opened new offices in Ramat Gan, Omer, Haifa, and Boston.
Expand
N/A
Pulsenmore Opens New Office in Ramat Gan
The article provides information about the office locations and trademarks of Pulsenmore Ltd.
growth-positive
GE Healthcare Invests $50M In Israeli Telehealth Firm Pulsenmore
GE Healthcare has entered into an agreement to invest up to $50 million in Israeli telehealth company Pulsenmore. The investment will support Pulsenmores goal to acquire U.S. FDA clearance and expand commercially. GE Healthcare will also partner with Pulsenmore to distribute its products in Europe and other markets. Pulsenmores platform has already been implemented in Israel in partnership with Clalit Health Services and has been adopted by physicians from Israels Sheba Medical Center. The investment will accelerate the adoption of Pulsenmores homecare ultrasound solutions and contribute to the growth of the homecare market.
InvestmentPartners
growth-positive
Home Ultrasound Developer Pulsenmore Establishes U.S. Operations and Appoints General Manager for North America
Pulsenmore Ltd., a home ultrasound developer, has announced the appointment of Hagar Spits as General Manager North America as the company establishes U.S. operations in Boston, Massachusetts. The company aims to tap into the growing U.S. telehealth market with its self-operated ultrasound solution for pregnant women. Pulsenmores solution has already been implemented in Israel in partnership with Clalit Health Services. Hagar Spits, who previously worked at Philips, brings 20 years of healthcare experience and is expected to lead the companys business growth successfully. Pulsenmore is traded on the Tel Aviv Stock Exchange.
PartnersExpand
growth-negative
פלסאנמור דיווחה על הכנסות זעומות, והמניה צנחה
פלסאנמור, an Israeli medical equipment company that develops portable ultrasound devices for home use, reported disappointing financial results. The company only recorded revenues of 1.58 million shekels in 2021, all of which were in the second half of the year. Despite having an agreement with Clalit Health Services since August 2020, which was expected to bring in revenues of about $6 million, the company has not seen the expected income. As a result, the companys stock fell by 19% last Thursday and added a further 6.5% drop today. The companys CEO, Dr. Elazar Sonnenschein, insists that nothing has changed and that they are satisfied with the agreement.
CustomersPartners
growth-positive
Israel's Pulsenmore Secures New Contract With Clalit Health Services For IVF Use
Israeli home ultrasound developer Pulsenmore has secured a multimillion-dollar contract with Clalit Health Services to supply its portable device for self-examination of follicles in IVF and fertility preservation processes. Clalit Health Services is expected to purchase thousands of units over four years, totaling approximately $11 million. This contract expands on Pulsenmores existing agreement with Clalit Health Services to provide its pregnant members with the companys flagship home device for fetal ultrasound. The new contract introduces the Pulsenmore FC device, which allows fertility patients to perform ultrasound scans at home and have them remotely assessed by healthcare professionals. Pulsenmore aims to be a major player in the global trend of adopting remote healthcare capabilities.
CustomersPartners
growth-positive
פלסאנמור חתמה על הסכם עם שירותי בריאות כללית
Pulsenmore, an Israeli company, has signed an agreement with Clalit Health Services for the acquisition of its home ultrasound product. Clalit will purchase thousands of units of the product, with a minimum annual order for 4 years, amounting to approximately $11 million. The product, Pulsenmore FC, is designed for self-examination of follicle size in women undergoing in vitro fertilization (IVF) and pregnancy preservation processes. The device is expected to enable scans even at times when womens health centers in hospitals are closed, thus creating significant value in diagnosing the precise time for egg retrieval.
AcquisitionCustomers
growth-positive
"האולטרסאונד הביתי יחולל מהפכה בכל תחום ההריון"
Pulsenmore, an Israeli company specializing in home ultrasound technology, has seen its stock value rise to over 700 million shekels since its IPO in June. The company raised 137 million shekels during the IPO, six times the amount raised in the last funding round before the IPO in March 2020. Pulsenmores portable home ultrasound device is designed for pregnant women, providing an alternative to hospital visits. The company recently launched a new product that allows fertility patients to conduct follicle tracking tests at home. Pulsenmore, founded in 2014, is just beginning its journey and has the burden of proof as to whether it can translate its interesting technology and the hungry market into significant revenues.
InvestmentExpand
growth-positive
פלסאנמור במו"מ עם קופת חולים מכבי למכירת מוצר האולטרסאונד הביתי של החברה
פלסאנמור עוברת פיילוט עם קופת חולים מכבי לרכישת מכשירי אולטרסאונד ביתיים בהיקף כספי של 6 מיליון דולר. ההסכם יכלול רכישה של מאות יחידות בשלב הראשון ואלפי יחידות בשלב השני. פלסאנמור ממשיכה בתוכניתה להרחבת הפרישה השיווקית ולצמיחה מואצת במכירות המוצר הראשון. החברה גם מפתחת מוצרים נוספים בתחום מעקב זקיקים ומוצרי אולטרסאונד לניטור מצב חולים כרוניים במחלות לב וכליות.
Customers
growth-positive
Home ultrasound co Pulsenmore raises $40m in TASE IPO
Pulsenmore, a home ultrasound device company, has raised $40 million in its TASE IPO at a company valuation of $190 million. The money raised will go to the company, with no offer to sell by existing shareholders. The demand for the companys product has increased due to the flourishing of the remote medicine sector during the Covid pandemic. Pulsenmore has an agreement with the Clalit health fund and has reported a significant orders backlog. The companys product is designed for home use by pregnant women to monitor fetal movements and reduce the need to visit hospital emergency departments.
InvestmentPublic Trading
growth-positive
Home ultrasound co Pulsenmore files for TASE IPO
Pulsenmore, a home ultrasound device company, has filed for an IPO on the Tel Aviv Stock Exchange. The company plans to raise $40 million at a valuation of $200 million. Despite having no revenue, Pulsenmore has reported an orders backlog of NIS 2.5 million for the first half of the year and NIS 15.7 million for the second half. The companys product is a home ultrasound device for pregnant women, aimed at reducing unnecessary visits to emergency departments. Pulsenmore faces competition from other companies producing mobile ultrasound devices, but its product is unique in its medical standards. The company has submitted its product for FDA approval and is awaiting a response.
Public TradingCustomers
growth-positive
Israel-based PulseNmore offers at-home ultrasounds amid Covid-19 concerns
PulseNmore has launched a new device that allows pregnant women to conduct ultrasound tests from their own homes. The device connects to a smartphone and uses advanced navigation, AI, and a mobile app to guide users through the scanning process and share the information with healthcare professionals. The tool aims to reduce hospital visits for pregnant women during the COVID-19 pandemic and help overworked physicians. Clalit Health Services, Israels largest HMO, has become the first healthcare provider to purchase the device, benefiting tens of thousands of pregnant members. PulseNmore is currently seeking FDA approval for implementation in the United States.
CustomersPartners
growth-positive
At-Home Ultrasounds for Pregnant Women Now A Reality: PulseNmore Launches World's First Self-Administered Handheld Tele-Ultrasound Device
Israeli startup PulseNmore has launched a handheld tele-ultrasound device that allows pregnant women to perform at-home ultrasound scans and receive feedback from a physician or sonographer. This reduces the need for hospital and doctor visits during COVID-19 and beyond. Clalit Health Services, Israels largest HMO, has signed a multi-year agreement to provide tens of thousands of its pregnant members with PulseNmores product. The device docks with a smartphone and utilizes advanced navigation and AI tools to guide users through the scanning process. Physicians or sonographers can review the scans remotely and provide guidance or reassurance. PulseNmore plans to enter key European markets in the near future.
Customers
growth-positive
4 emerging technologies to take the worry out of pregnancy
The article discusses four innovative femtech solutions emerging from Israel that aim to provide pregnancy monitoring and reduce unnecessary hospital visits. The first solution, HeraBEAT by HeraMED, is a smartphone-based fetal heartbeat monitor that allows expectant mothers to monitor their fetus heartbeat at home and share the data securely with healthcare providers. The second solution, Instinct by PulseNmore, is an at-home handheld ultrasound system that enables women to record and send images to their healthcare provider for evaluation. The third solution, Lioness by PregnanTech, is a disposable silicone ring that prevents preterm birth by surrounding the cervix. The fourth solution, Invu by Nuvo, is a remote, noninvasive pregnancy monitoring wearable that measures markers of fetal and maternal wellbeing. These innovations aim to provide greater control and peace of mind to expectant mothers.
Customers
growth-positive
New Device Lets Pregnant Moms Take Ultrasound Pictures of Their Baby on Their Phone - LifeNews.com
PulseNmore LTD, an Israeli company, is developing a handheld ultrasound device that can connect to smartphones and allow expecting mothers to view their unborn babies. The device can take ultrasound images and be used to communicate with doctors. The estimated cost of the device is $190. The device is intended to provide a calming effect for pregnant women and allow them to see their fetus when they are stressed. The device is not meant for medical diagnosis or measurements. The article highlights the advancements in ultrasound technology and the ability for parents to see their unborn babies in the womb.
Customers
growth-positive
Israeli device would let pregnant women take ultrasound scans on phone
Israeli startup PulseNmore is nearing completion of a handheld ultrasound device that connects to smartphones, allowing pregnant women to check on the health of their baby. The device can display ultrasound images on the smartphone screen and send them to the womans doctor for examination. The device has been successfully tested in the United States and is awaiting approval from the Health Ministry. Once approved, it will retail for around NIS 700 ($190) and can be used for up to 25 ultrasound checks. The device aims to provide a calming effect for pregnant women and reduce the need for costly ultrasound tests.
CustomersPartners
